Age related differences in Norfloxacin pharmacokinetic behaviour following intravenous and oral administration in sheep

Veterinary Quarterly

Volumn 19, Issue 4, 1997, Pages 145-150

  González, Fernando ^a   Rodriguez C ^a   Nieto, J ^b   De Vicente, M L ^a   San Andres M D ^a   San Andres M I ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTICLE; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; MALE; NONHUMAN; SHEEP; VETERINARY MEDICINE;

ABSORPTION; ADMINISTRATION, ORAL; AGING; ANIMALS; ANTI-INFECTIVE AGENTS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FEMALE; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; NORFLOXACIN; RANDOM ALLOCATION; SHEEP;

ANIMALIA; OVIS ARIES;

EID: 0031427121     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.1997.9694760     Document Type: Article

References (55)

1. Backer P de. Comparative neonatal pharmacokinetics. In: Comparative Veterinary Pharmacology, Toxicology and Therapy. Edited by: Miert ASJPAM van, Bogaert MG, Debackere M. MTP Press Limited, Lancaster, England, 1985: 161–71.
2. Backer P de, and Bogaert MG. Drug bioavailability in the developing ruminant. In: Ruckebusch Y, Toutain PL, Koritz GD. Veterinary Pharmacology and Toxicology. MTP Press Limited, Lancaster, 1983: 133–40.
3. Baggot JD. Principles of drug disposition in domestic animals: The basis of veterinary clinical pharmacology. Philadelphia: Saunders WB, 1983.
4. Bogan JA, and Marriner SE. The rumen as a pharmacokinctic compartment. In: Ooms LAA, Decryse AD, Miert ASJPAM van. Physsiological and Pharmacological Aspects of the Reticulorumen. Martinus Nijhoff Publishers, 1987; 253–70.
5. Bradley BD, Allen EH, Showalter BH, and Colaianne JJ. Comparative pharmacokinetics of chlortetracycline in milkfed versus conventionally feed calves. J Vet Pharmacol Therap 1982; 5: 267–78.
6. Dalton RG. Renal function in neonatal calves: urea clearance. Br Vet J 1968; 124: 451–59.
7. Eltom SE, Guard CL, and Schwark WS. The effect ofage on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats. J Vet Pharmacol Therap 1993; 16: 141–51.
8. Eltom SE, Babish JG, and Schwark WS. The postnatal development of drug metabolizing enzymes in hepatic, pulmonary and renal tissues of the goat. J Vet Pharmacol Therap 1993; 16: 152–63.
9. Faichney GJ. The kinetics of particulate matter in the rumen. In: Milligan LP, Grovum WL, Dobson A. Control of Digestion and Metabolism in ruminants. Englewood, Cliffs (New Jersey), 1984; 173–95.
10. Forchetti C. High-performance liquid chromatography procedure for the quantitation of norfloxacin in urine, serum and tissues. J Chromatogr 1984; 309: 177–82.
11. Friis C. Postnatal development of renal function in goats. In: Ruckebusch Y, Toutain PL, Koritz GD. Veterinary Pharmacology and Toxicology. Lancaster, MTP Press Limited, 1983: 57–62.
12. Friis C. Disposition kinetics of metronidazole in the cow. Acta Vet Scand 1991; 87 Suppl: 155–7.
13. Friis C. Danofloxacin in calves: pharmacokinetics and penetration into the respiratory tract tissue. Acta Vet Scand 1991; 87 Suppl: 104–6.
14. Giles CJ, Magorigle RA, Grimshaw WRT, Tanner AC, Risk JE, Lynch MJ, et al. Clinical pharmacokinetics of parenterally administrered danofloxacin in cattle. J Vet Pharmacol Therap 1991; 14: 400–10.
15. Gips M, Barel S, and Soback S. Norfloxacin disposition kinetics and residues in calves after intramuscular administration of norfloxacin nicotinate. Proc 6th EAVPT Congress. Eds. Lees P, Baggot D, Chantler P et al. Oxford, Blackwell Sci Publ, 1994: 77.
16. Gips M, and Soback S. Norfloxacin nicotinate pharmacokinetics in unweaned and weaned calves. J Vet Pharmacol Therap 1996; 19: 130–4.
17. Gonzalez F. Comportamiento farmaeocinético de la norfloxacina en óvidos de diferentes edades (dissertation). Madrid Universidad Complutense, 1994.
18. Gonzalez F, Nieto J, San Andres MD, Vicente ML de, Rodriguez C San Andres MI. Influencia de la distribución reticulo-ruminal en la farmacocinética de la norfloxacina en óvidos. Proceedings of the X Jornada Nacionaly IV Lationoamericana de Farmacologia y Terapéutica Veterinaria. Argentina: Esperanza, Santa Fe, 1995.
19. Guard CL, Schwark WS, Friedman DS, Blackshear P, and Haluska M. Age-related alterations in trimethoprim a sulfadiaiine disposition following oral or parenteral administration in calves. Can J Vet Res 1986; 50: 342–6.
20. Kaartinen L, Salonem M, Alli L, and Pyordla S. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous infections in lactating cows. J Vet Pharmacol Therap 1995; 18: 357–62.
21. Kawalek JC, and El Said KR. Maturational development of drugmetabolizing enzymes in sheep. Am J Vet Res 1990; 51: 1736–41.
22. Kawalek JC, and El Said KR. Comparison of maturation of drug-metabolizing enzymes in calves with functioning or nonfunctioning rumen. Am J Vet Res 1994; 55: 1579–86.
23. Machida M, Kusajima H, Aijima H, Maeda A, Ishida R, and Uchida H. Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicol Appl Pharmacol 1990; 105: 403–12.
24. Mann DD, and Frame GM. Pharmacokinetic study of danofloxacin in cattle and swine. Am J Vet Res 1992; 53: 1022–6.
25. Metzler CM, and Weiner DL. PC NONLIN user’s guide. Lexington, Statistical Consultants 1992.
26. Mevius DJ, Breukink I H, Jansen T, Guelen PJM, and De Greve B. Oral absorption and bioavailability of flumequine in veal calves. Vct Quart 1989; 11 (4): 232–41.
27. Mevius DJ, Breukink H, and Micrt ASJPAM van. In vitro activity of flumequine in comparison with several other antimicrobial agents against five pathogens isolated in calves in Netherlands. Vet Quart 1990; 12 (4): 212–21.
28. Mevius DJ, Breukink I H, Guelen PJM, Jansen T, and De Greve B. Pharmacokinetics, metabolism and oral clearance of flumequine in veal calves. J Vet Pharmacol Therap 1990; 13: 159–69.
29. Mevius DJ, Breukink HJ, Mien ASJPAM van, Kessels BGF, Johse AS, and Smit JAH. Effects of experimentally induced Pasteurella hoemolytica infection in dairy calves on the pharmacokinetics of flumequine. J Vet Pharmacol Therap 1991; 14: 174–84.
30. Montay G, Blain Y, Roquet F, and Lellir A. I ligh-perfomance liquid chromatography of pefloxac in and its main active metabolites in biological fluids. J Chromatogr 1983; 272: 359–65.
31. Minim MJ, Lloveria P. Santos MP, Abadia AR, Aramayona JJ, and Braga. MA. Pharmacokinet ics of ciprofloxacin in sheep after single intravenous or intramuscular administration, Vet Quart 1996; 18 (2): 45–8.
32. Nielsen P. Romary A, and Rasmussen F. Sulphadoxinc and trimethoprim in goats and cows: absorption fraction, halflines and the degrading effect of the ruminal flora. J Vet Pharmacol Thcrap 1978; 1: 37–46.
33. Nouws JFM, Vree TB, Baakman M, Driessens F, Breukink H.I, and Mevius D. Age and dosage dependency in the plasma disposition and the renal clearance of sul fadimidinc and its N4-acetyl and hydroxyl metabolites in calves and cows. Am J Vet Res 1986; 47: 642-9
34. Nouws JFM, Mevius DJ, Vree TB, Baars AM, and Lamcnsen J. Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Vet Quart 1988; 10 (3): 156–63.
35. Powers J. Statistical analysis of pharmacokinetic data. J Vet Pharm Therap 1990; 13: 408–14.
36. Prescott JF, and Yielding KM. In vitro susceptibility of selected veterinary bacterial pathogcncs to ciprofloxacin, enrofloxacin and norfloxacin. Can J Vet Res 1990; 54: 195-7
37. Reiche R. Drug disposition in the newborn. In: Ruckebusch Y, Toutain PL, Koritz GD. Veterinary Pharmacology and Toxicology, Lancaster, MTP Press Limited, 1983: 49–55.
38. Richez P, Dellac B, Froyman R, and Jong A de. Pharmacokinetics of enrofloxacin in calves and adult cattle after single and repeated subcutaneous infections. Proc 6th EAVPT Congress. Eds Lees P, Baggot D, Chantler P, et al. Oxford: Blackwell Sci Publ, 1994: 232–4.
39. Riond JL, Tyczkowska K, and Riviere JE. Pharmacokinetics and metabolic inertness of doxycycline in calves with mature or inmature rumen function. Am J Vet Res 1989; 50: 1329–33.
40. Santos MP. Estudio farmacocinético de las curvas de nivel plasmático y excreción urinaria obtenidas tras la administraci6n de ciprofloxacina en oveja por via oral e intramuscular (dissertation). Facultad de Veterinaria, Universidad de Zaragoza, 1992.
41. Shoaf SE, Schwark WS, and Guard CL. The effect of age and diet an sulfadiazine/trimethoprim disposition following oral and subcutaneous administration to calves. J Vet Pharmacol Therap 1987: 10: 331–45.
42. Shoaf SE, Schwark WS, and Guard CL. The development of hepatic drug metabolizing enzyme activity in the neonatal calf and its effect on drug disposition. Drug Metab Dispos 1987; 15: 676–81.
43. Soback S, Ziv G, Kurtz B, and Paz R. Clinical pharmacokinetics of five oral cephalosporins in calves. Res Vet Sci 1987; 43: 166–72.
44. Soback S. et al. The effects of age (weaning) on the intravenous pharmacokinetics of norfloxacin in calves. McKellar Q (Glasgow University). Proceedings of the postCongress Pharmacokinetics Wokshop 6th EAVPT. Effects of physiological and pathological changes on pharmacokinetics of drugs in animals, 1994: 2.
45. Sörgel F, and Kinzig M. Pharmacokinetics of gyrase inhibitors, Part 2: renal and hepatic elimination pathways and drug interactions. Am J Med 1993; 94 (3A): 56–69.
46. Sutter HM, Riond JL, and Wanner M. Comparative pharmacokinctics of aditoprin in milk-fed and conventionally fed calves of different ages. Res Vet Sci 1993; 54: 86–93.
47. Sweeney RW, Divers T.I, Benson C, and Colatos C. Pharmacokinetics of rifampin in calves and adult sheep. J Vet Pharmacol Therap 1988; 11: 413–6.
48. Vancutscm PM, Babish JG, and Schwark WS. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 1990; 80 (2): 173–86.
49. Vynckier LJ, and Debackere M. Plasma ronidazole concentrations in sheep after intravenous, oral, intraruminal and intra-abomasal administration. J Vet Pharmacol Therap 1993; 16: 70–8.
50. Watson ADJ, Gogh H Van, Deurzen PJM van, and Duin CTM van. Pharmacokinetics of three sulphonamides in ruminant and preruminant kids. Res Vet Sci 1987; 43: 208–16.
51. Witkamp RF, Klooster GAE van, Nijmeijer SM, Kolker HJ, Noordhoek J, and Miert ASJPAM van. Hormonal regulation of oxidative drug metabolism in the dwarf goat. The effect of sex and hormonal treatment on plasma disposition and metabolite formation of sulphadimidine. J Vet Pharmacol Therap 1993; 16: 55–62.
52. Yamaoka K, Nakagawa T, and Uno T. Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetics. J Pharmacokinetics and Biopharmaceutics 1978; 6: 165–75.
53. Ziv G. Clinical pharmacology of oxolinic acid in young dairy calves. Am J Vet Res 1976; 37 (5): 513–16.
54. Ziv G, Soback S. Bor A, and Kurtz B. Clinical pharmacokinetics of flumequine in calves. J Vet Pharmacol Therap 1986; 9: 171–82.
55. Ziv G. Post antibiotic effect (PAE) of cephalosporins and quinolones on Gram negative animal pathogens. Abst 16th Interntl Congr Chemother Jerusalem, 1989: 27.